Slow down your natural ageing clock now!

Univ. of Virginia, School of Medicine researchers discovery  – a key driver of chronic inflammation causing ageing to accelerate in human bodies.  This finding can potentially lead to a position where we could slow down our natural ageing clock  and so live longer,healthier lives, where many age related conditions like heart disease and devastating brain…

Read More

Arterial hypertension – a leading cause of death

Arterial hypertension – a leading cause of death. Partly due to ageing, the rising incidence of obesity, and socio economic and environmental changes, its incidence increases worldwide. Hypertension commonly coexists with Type 2 diabetes, obesity, dyslipidaemia, sedentary lifestyle, and smoking leading to risk amplification. Blood pressure lowering by lifestyle modifications and anti hypertensive drugs reduce…

Read More

EU Commission’s revised pharma legislation.

European Institute of Women’s Health Press release:   For Immediate release The European Institute of Women’s Health (EIWH) welcomes the European Commission’s revised pharmaceutical legislation. The EIWH promotes women’s health in policy and research, and it is of utmost importance that women’s needs are reflected in this important piece of legislation. This revision comes at a…

Read More

Announcing: EIWH Position Paper on Covid-19

Protecting our health now and in future! The EIWH has drawn up an initial position paper on the current Coronavirus – COVID-19 pandemic. We have reviewed the immediate impacts of the pandemic, particularly to hghlight the needs and benefits of ensuring that everything that can be learned from our current experiences is used practically to…

Read More

Vaccination reduces illness in children!

Vaccination reduces illness in children A recent study shows that the UK’s vaccination programme against group B meningococcal disease (MenB) has reduced cases of meningitis and septicaemia in young children by almost two-thirds. The UK was the first country to offer this new vaccine against MenB in 2015 and since then approximately 90% of infants…

Read More

Guide on biosimilars for healthcare professionals

EMA published the information guide on biosimilars for healthcare professionals in 15 additional EU languages. It now includes Bulgarian, Czech, Danish, Greek, Estonian, Finnish, Croatian, Hungarian, Lithuanian, Latvian, Maltese, Romanian, Slovak, Slovenian and Swedish. These educational materials on biosimilar, and link to the Q&A for patients, can be found on EMA’s webpage on biosimilar medicines…

Read More

ConcePTION – use of medication in pregnancy

ConcePTION – use of medication during pregnancy and lactation ConcePTION is a large Horizon 2020 programme, bringing partners from all over Europe together to focus on the uses of medication during pregnancy and lactation. The European Institute of Women’s Health (EIWH) are a partner in this project. ConcePTION aims to reduce uncertainty around the safety…

Read More

Use in pregnancy and women of childbearing age of valproate

Review of valproate use in pregnancy and women of childbearing age EMA to consider risks of these medicines require further restrictions of use The European Medicines Agency (EMA) has started a review looking at the use of valproate containing medicines in the treatment of women and girls who are pregnant or of childbearing age. These…

Read More

Final guidance for treating neuroendocrine tumours (NETs)

Guidance issued by NICE (England) for treating neuroendocrine tumours (NETs) Final guidance recommending everolimus (Infinitor, Novartis) and sunitinib (Sutent, Pfizer) to treat neuroendocrine tumours (NETs). The drugs are recommended as an option for pancreatic NETs that cannot be operated on and have progressed. Everolimus is also recommended as an option for those with NETs of…

Read More